News & Media

|News & Media
News & Media2018-11-29T16:30:39+00:00
11thApr, 2019

PharmaVOICE Features Firma Clinical Research Executives Darcy Forman and Michael Keens’ Thoughts on Patient Engagement

April 11th, 2019|

Firma Clinical Research leadership figures, Darcy Forman and Michael Keens, were featured in the April 2019 edition of PharmaVOICE. Forman and Keens share information and perspective on patient-focused advancements in wearables, patient engagement liaisons and integrating patient input to reduce burden of treatment. Read the full article here.

2ndAug, 2017

Press Release: Firma provides support associated with FDA approval of Baxdela™

August 2nd, 2017|Tags: |

Firma Clinical Research, an ISO quality management-certified clinical research organization (CRO), is pleased to announce its contribution to the FDA approval of Melinta Therapeutics’ lead antibiotic, Baxdela™ (delafloxacin), for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria.